CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Ceva Sante Animale SA is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Ceva Sante Animale SA
10 Avenue de La Ballastiere
Phone: +33 557554040p:+33 557554040 Libourne, 33500  France
This is a Subsidiary, click here for the Parent Company
Business Summary
Ceva Santé Animale SA is a global animal health company. The Company develops and commercializes drugs and related products aimed at companion animals, poultry, swine, sheep and goats, and cattle. It offers a range of vaccines and vaccination equipments, drugs used for the treatment of heart problems, locomotion and behavior disorders, as well as antibiotic therapies and reproduction management products and other pharmaceuticals and products.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
---YesYes--

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
--Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations

Business Names
Business Name
Biomune Company
Ceva Animal Health
CEVA SANTE ANIMALE


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, December 2, 2024